At Chembio, our mission is to be a leader in the development, manufacture and commercialization of diagnostic solutions. We are dedicated to delivering exceptional products that provide ease of use, and rapid and accurate results at the point-of-care (POC). As a global company, we are committed to innovation and the highest quality standards.
chembio.com.
chembio.com.
Location: United States, New York, Hauppauge
Investors 1
| Date | Name | Website |
| - | Perceptive... | perceptive... |
Mentions in press and media 15
| Date | Title | Description |
| 13.03.2024 | HIV Point of Care (POC) Tests Pipeline Landscape Report 2023: Comparative Analysis of Products at Different Stages of Development and Clinical Trials in Progress | - |
| 20.10.2022 | Chembio Diagnostics to Report Third Quarter 2022 Financial Results on November 3, 2022 | HAUPPAUGE, N.Y., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the third qu... |
| 21.07.2022 | Chembio Diagnostics to Report Second Quarter 2022 Financial Results on August 4, 2022 | HAUPPAUGE, N.Y., July 21, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the second q... |
| 21.04.2022 | Chembio Diagnostics to Report First Quarter 2022 Financial Results on May 5, 2022 | HAUPPAUGE, N.Y., April 21, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the first q... |
| 17.02.2022 | Chembio Diagnostics to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022 | HAUPPAUGE, N.Y., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the fourth q... |
| 13.12.2021 | As the pandemic raged, at least 75 lawmakers bought and sold stock in companies that make COVID-19 vaccines, treatments, and tests | At least 75 federal lawmakers held shares of Moderna, Johnson & Johnson, or Pfizer in 2020. Lawmakers’ holding stock in these companies has prompted ethical concerns. Several other lawmakers traded shares of companies with a direct stak... |
| 21.10.2021 | Chembio Diagnostics to Report Third Quarter 2021 Financial Results on November 4, 2021 | HAUPPAUGE, N.Y., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the third qu... |
| 23.07.2021 | Chembio Diagnostics : Receives $4 Million HIV Test Purchase Order Supported by The Global Fund (Form 8-K) | Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund HAUPPAUGE, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on ... |
| 22.07.2021 | Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund | HAUPPAUGE, N.Y., July 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, announced its receipt today of a $4 million purchase order from the Part... |
| 22.07.2021 | Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund | Chembio Diagnostics, Inc. announced its receipt of a $4 million purchase order from the Partnership for Supply Chain Management (PFSCM), supported by The Global Fund, for the purchase of Chembios HIV 1/2 STAT-PAK Assay for shipment to Ethi... |
Show more